Expression of serum microRNAs (miR-222, miR-181, miR-216) in human hepatocellular carcinoma and its clinical significance

National Medical Journal of China

Volumn 93, Issue 23, 2013, Pages 1830-1832

  Zhan, Mei Xiao ^a   Li, Yong ^a   Hu, Bao Shan ^a   Shao, Pei Jian ^a   Meng, Qing Wen ^a   He, Xu ^a   Huang, Jian Wen ^a   Lu, Li Gong ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Liver neoplasms; Prognosis; Serum

Indexed keywords

ALPHA FETOPROTEIN; MICRORNA; MICRORNA 181; MICRORNA 216; MICRORNA 222; UNCLASSIFIED DRUG;

ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; OVERALL SURVIVAL; PORTAL VEIN THROMBOSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; UP-REGULATION;

EID: 84879423085     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2013.23.016     Document Type: Article

References (11)

1. Parkin D M, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin, 2005, 55:74-108.
2. 2010, 90:3391-3394.
3. 2008, 88:1683-1686.
4. 2011, 28:479-480.
5. Ladeiro Y, Couchy G, Balabaud C, et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology, 2008, 47:1955-1963.
6. Wu K, Ding J, Chen C, et al. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development. Hepatology, 2012, 56:2255-2267.
7. Mitchell P S, Parkin R K, Kroh E M, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A, 2008, 105:10513-10518.
8. 2011, 13:370-372.
9. Resnick K E, Alder H, Hagan J P, et al. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol, 2009, 112:55-59.
10. Wong Q W, Ching A K, Chan A W, et al. MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. Clin Cancer Res, 2010, 16:867-875.
11. Ji J, Yamashita T, Wang X W. Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma. Cell Biosci, 2011, 1:4.